sublingual tablets [Regulatives / Guidelines]

posted by nobody – 2014-11-21 12:33 (4233 d 10:34 ago) – Posting: # 13905
Views: 4,991

Hi!

Found a case of a (nearly) European Agency (UK :-D ) granting a biowaiver for a chewable tablet, so apparently this type of formulation is considered closer to a conventional IR tablet, from regulatory perspective, although the 2010 EMA guidance on BE considers chewable tablets to be comparable to ODT, for which BE is required...

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
168 visitors (0 registered, 168 guests [including 59 identified bots]).
Forum time: 00:07 CEST (Europe/Vienna)

Scientists often have a naïve faith that
if only they could discover enough facts about a problem,
these facts would somehow arrange themselves
in a compelling and true solution.    Theodosius Dobzhansky

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5